Trends in Aggregate Use and Associated Expenditures of Antihyperglycemic Therapies Among US Medicare Beneficiaries Between 2012 and 2017-Reference-Cited by-同舟云学术

Trends in Aggregate Use and Associated Expenditures of Antihyperglycemic Therapies Among US Medicare Beneficiaries Between 2012 and 2017

Published:2020-01-01 Issue:1 Volume:180 Page:141
ISSN:2168-6106
Container-title:JAMA Internal Medicine
language:en
Short-container-title:JAMA Intern Med

Author:

Sumarsono Andrew¹,Everett Brendan M.²,McGuire Darren K.³,Fonarow Gregg C.⁴,Butler Javed⁵,Pandey Ambarish³,Vaduganathan Muthiah²

Affiliation:

1. Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas

2. Brigham and Women’s Hospital Heart and Vascular Center, Harvard Medical School, Boston, Massachusetts

3. Division of Cardiology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas

4. Ahmanson-UCLA Cardiomyopathy Center, University of California, Los Angeles, Los Angeles

5. Department of Medicine, University of Mississippi Medical Center, Jackson

Publisher

American Medical Association (AMA)

Subject

Internal Medicine

Link

https://jamanetwork.com/journals/jamainternalmedicine/articlepdf/2751944/jamainternal_sumarsono_2019_ld_190040.pdf

Reference4 articles.

1. 9. Pharmacologic approaches to glycemic treatment: Standards of Medical Care in Diabetes-2019.;American Diabetes Association;Diabetes Care,2019

2. Trends in Medicaid prices, market share, and spending on long-acting insulins, 2006-2018.;Hernandez;JAMA,2019

3. Time trends in prescribing of type 2 diabetes drugs, glycaemic response and risk factors: a retrospective analysis of primary care data, 2010-2017.;Dennis;Diabetes Obes Metab,2019

4. Centers for Disease Control and Prevention. National Diabetes Statistics Report, 2017: Estimates of Diabetes and Its Burden in the United States. https://www.cdc.gov/diabetes/pdfs/data/statistics/national-diabetes-statistics-report.pdf. Accessed August 28, 2019.

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Heart Failure and Diabetes;Textbook of Diabetes;2024-01-12

2. Temporal trends in cardiovascular outcomes and costs among patients with type 2 diabetes;American Heart Journal;2023-11

3. Sodium Glucose Cotransporter-2 Inhibition for Acute Myocardial Infarction;Journal of the American College of Cardiology;2022-05

4. Changes over time in the cardiovascular risk profile of type 2 diabetes from 2007 to 2020: A community‐based study;Diabetes, Obesity and Metabolism;2022-04-11

5. Effects of empagliflozin on insulin initiation or intensification in patients with type 2 diabetes and cardiovascular disease: Findings from the EMPA‐REG OUTCOME trial;Diabetes, Obesity and Metabolism;2021-10-07